Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Combined pediatric neuroscience programs at Barrow Neurological Institute

St. Joseph's Hospital and Medical Center and Phoenix Children's Hospital jointly announced this week their pediatric neuroscience programs are combining under the newly formed Barrow Neurological Institute at Phoenix Children's Hospital.

24 Jun 2011

Growth-braking tumor-suppressor gene slows growth of childhood brain tumors

Johns Hopkins researchers have found a likely explanation for the slow growth of the most common childhood brain tumor, pilocytic astrocytoma. Using tests on a new cell-based model of the tumor, they concluded that the initial process of tumor formation switches on a growth-braking tumor-suppressor gene, in a process similar to that seen in skin moles.

24 Jun 2011

Anonymous donor makes generous gift for mesothelioma research

The UH Cancer Center has received a $3.58 million gift from an anonymous donor to support the mesothelioma research of Dr. Michele Carbone, director of the UH Cancer Center. Carbone and colleagues, who include Drs. Haining Yang and Giovanni Gaudino, have made a series of recent scientific breakthroughs that will lead to new ways to prevent and treat the disease

24 Jun 2011

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Endo Pharmaceuticals announced today that it received notification from the U.S. Food and Drug Administration (FDA) that Endo's complete response to the FDA's Jan. 7, 2011 Action Letter relating to Endo's new drug application (NDA) for a new formulation of OPANA ER has been accepted.

24 Jun 2011

Millennium reports ongoing MLN8237 Phase II study results on non-Hodgkin lymphoma

Millennium: The Takeda Oncology Company today announced the presentation of results from an ongoing Phase II study of MLN8237, an investigational Aurora A kinase inhibitor, in patients with relapsed/refractory aggressive B-cell and T-cell non-Hodgkin lymphoma.

24 Jun 2011

Longer looks: Prenatal care for dads; rise in bipolar diagnosis for children

Perhaps it's because mom has the burgeoning belly, but dads have largely been left out of prenatal care. That could be damaging to the family's health, contends research in a recent issue of the Journal of Advanced Nursing.

24 Jun 2011

Health Canada grants market authorization for Sanofi-aventis Jevtana to treat prostate cancer

Sanofi-aventis announced today that Health Canada has granted market authorization for Jevtana injection in combination with prednisone for the treatment of patients with metastatic castration resistant prostate cancer, previously treated with a docetaxel-containing treatment regimen.

24 Jun 2011

Arno AR-67 Phase II clinical study for glioblastoma meets pre-defined interim goals

Arno Therapeutics, Inc. announced today that its Phase II clinical study of AR-67 has met pre-defined interim goals for patients with glioblastoma multiforme (GBM) who were not previously treated with Avastin and will continue toward completion.

23 Jun 2011

Varian receives 2011 R&D 100 Award for TrueBeam system for image-guided radiotherapy and radiosurgery

Varian Medical Systems today announced that the company's TrueBeam system for image-guided radiotherapy and radiosurgery has received a 2011 R&D 100 Award from R&D Magazine. This annual award salutes the 100 most technologically significant products of the prior year, spanning many categories, from biomedical products to consumer items.

23 Jun 2011

Proton beam radiotherapy appears to control breast cancer with minimal side-effects

A treatment that has virtually no side effects has been found to be an effective weapon for fighting early-stage breast cancer, according to results of a clinical trial conducted at Loma Linda University Medical Center.

23 Jun 2011

PNAS publishes Roche manuscript on generation of human bispecific IgG antibodies

The Roche manuscript: "Immunoglobulin Domain Crossover as a Generic Approach for the Production of Bispecific IgG Antibodies" has been published in the prestigious Proceedings of the National Academy of Sciences of the USA.

23 Jun 2011

Daewoong, Medivir sign distribution agreement for Xerclear in China and Hong Kong

Medivir AB, a research-based specialty pharmaceutical company focused on infectious diseases, today announced that it has signed an agreement with Daewoong Pharmaceutical Co. Ltd. to exclusively distribute Medivir's unique cold sore treatment Xerclear in China and Hong Kong.

23 Jun 2011

CPDC, UHN to advance use of medical isotopes for cancer treatment and diagnosis

CanProbe, a unique, not-for-profit joint venture to advance the use of medical isotopes for diagnosing and treating cancer and other serious diseases, was announced today by the Centre for Probe Development and Commercialization (CPDC) and the University Health Network.

23 Jun 2011

AstraZeneca, Jubilant announce delivery outcomes and early success in Pain therapeutic area

Biosys Ltd., Bengaluru, based subsidiary of Jubilant Life Sciences Ltd., and AstraZeneca, today announced another successful delivery of an early stage milestone in the Pain therapeutic area.

23 Jun 2011

Experts to focus on Shwachman-Diamond Syndrome at New York Academy of Sciences conference

On June 28-30, 2011, the New York Academy of Sciences will bring together scientists and clinicians from a wide range of subspecialties, in addition to patients and caregivers, to discuss the most important recent advances in our understanding of the clinical features, management, and treatment of Shwachman-Diamond Syndrome (SDS)-a rare disorder involving multiple organ systems and affecting children and young adults.

23 Jun 2011

Barrow Neurological Institute announces Phoenix Children’s Hospital as new pediatric affiliate

St. Joseph’s Hospital and Medical Center and Phoenix Children’s Hospital jointly announced today their pediatric neuroscience programs are combining under the newly formed Barrow Neurological Institute at Phoenix Children’s Hospital.

22 Jun 2011

Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has completed enrollment in its Phase IIb clinical trial of Serdaxin to treat major depressive disorder (MDD).

22 Jun 2011

Twelve institutions receive NPCRC and American Cancer Society grants for palliative care research

The American Cancer Society and the National Palliative Care Research Center (NPCRC) are awarding $2 million in research grants to researchers at 12 institutions for studies aimed at reducing suffering for seriously ill patients and their family caregivers.

22 Jun 2011

Dr. Reddy's Labs launches generic version of LEVAQUIN tablets in the U.S.

Dr. Reddy's Laboratories announced today that it has launched Levofloxacin tablets, a bioequivalent generic version of LEVAQUIN tablets in the US market on June 20, 2011, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Levofloxacin tablets.

22 Jun 2011

ImmunoCellular Therapeutics receives U.S. patent for cancer vaccine technology

ImmunoCellular Therapeutics, Ltd., a biotechnology company focused on the development of novel immune-based cancer therapies, announced the issuance of a U.S. patent relating to a technology for the treatment of cancer for which the Company holds an exclusive, worldwide license.

22 Jun 2011

Oncology News and Research

Further Reading

Combined pediatric neuroscience programs at Barrow Neurological Institute

Growth-braking tumor-suppressor gene slows growth of childhood brain tumors

Anonymous donor makes generous gift for mesothelioma research

Endo's complete response for new formulation of OPANA ER NDA accepted by the FDA

Millennium reports ongoing MLN8237 Phase II study results on non-Hodgkin lymphoma

Longer looks: Prenatal care for dads; rise in bipolar diagnosis for children

Health Canada grants market authorization for Sanofi-aventis Jevtana to treat prostate cancer

Arno AR-67 Phase II clinical study for glioblastoma meets pre-defined interim goals

Varian receives 2011 R&D 100 Award for TrueBeam system for image-guided radiotherapy and radiosurgery

Proton beam radiotherapy appears to control breast cancer with minimal side-effects

PNAS publishes Roche manuscript on generation of human bispecific IgG antibodies

Daewoong, Medivir sign distribution agreement for Xerclear in China and Hong Kong

CPDC, UHN to advance use of medical isotopes for cancer treatment and diagnosis

AstraZeneca, Jubilant announce delivery outcomes and early success in Pain therapeutic area

Experts to focus on Shwachman-Diamond Syndrome at New York Academy of Sciences conference

Barrow Neurological Institute announces Phoenix Children’s Hospital as new pediatric affiliate

Enrollment complete in Rexahn's Serdaxin Phase IIb clinical trial for major depressive disorder

Twelve institutions receive NPCRC and American Cancer Society grants for palliative care research

Dr. Reddy's Labs launches generic version of LEVAQUIN tablets in the U.S.

ImmunoCellular Therapeutics receives U.S. patent for cancer vaccine technology

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News